Revenue
2018
2019
2020
2021
2022
2023
2024
2025
LIFECORE BIOMEDICAL, INC. DE (LFCR)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $128.9M | $128.3M | $103.3M | $111.3M | $100.9M | $160.1M | $557.6M | $524.2M | $469.8M | $476.9M | $539.3M | $476.8M | $441.7M | $317.6M | $276.7M | $238.2M |
| Gross profit | $40.3M | $41.9M | $28.0M | $39.1M | $38.9M | $39.4M | $81.0M | $78.3M | $79.2M | $66.8M | $65.4M | $62.6M | $62.8M | $52.1M | $46.7M | $33.8M |
| Research & development | $8.3M | $8.6M | $8.7M | $7.8M | $6.7M | $7.6M | $11.5M | $12.8M | $9.5M | $7.2M | $7.0M | $7.2M | $9.3M | $9.6M | $9.3M | $4.4M |
| Operating expenses | — | $50.7M | $49.8M | $50.9M | $47.8M | $65.3M | $75.5M | $64.8M | $64.5M | $87.4M | $46.9M | $42.4M | $37.9M | $37.6M | $38.7M | $25.8M |
| Operating income | −$17.2M | −$8.8M | −$21.8M | −$11.8M | −$8.8M | −$25.9M | $5.5M | $13.6M | $14.7M | −$20.6M | $18.5M | $20.2M | $24.9M | $14.6M | $8.0M | $8.0M |
| EBITDAderived | −$9.2M | −$890,000 | −$8.6M | $6.3M | $11.0M | −$7.0M | $20.7M | $26.0M | $25.3M | −$11.2M | $25.6M | $27.3M | $32.2M | $20.2M | $13.3M | $11.3M |
| Net income | −$38.7M | $12.0M | −$99.6M | −$116.7M | −$32.3M | −$38.2M | $411,000 | $24.8M | $10.6M | −$11.6M | $13.5M | $19.1M | $22.6M | $12.7M | $3.9M | $4.0M |
| Basic EPSper diluted share | -$1.27 | $0.39 | -$3.32 | -$3.97 | -$1.10 | -$1.31 | $0.01 | $0.90 | $0.39 | -$0.43 | $0.50 | $0.72 | $0.87 | $0.49 | $0.15 | $0.15 |
| Diluted EPSper diluted share | -$1.27 | $0.33 | -$3.32 | -$3.97 | -$1.10 | -$1.31 | $0.01 | $0.89 | $0.38 | -$0.43 | $0.50 | $0.71 | $0.85 | $0.49 | $0.15 | $0.15 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 28, 2025Form 4 | English Aron R. +4TenPercentOwner | SellCommon Stock · indirect | 150.4K | $7.12 | $1.07M | 264.2K |
| May 27, 2025Form 4 | English Aron R. +4TenPercentOwner | SellCommon Stock · indirect | 1.14M | $6.50 | $7.41M | 414.6K |
| May 23, 2025Form 4 | English Aron R. +4TenPercentOwner | SellCommon Stock · indirect | 96.1K | $6.75 | $648.9K | 1.55M |
| May 13, 2025Form 4 | 22NW Fund GP, LLC +4TenPercentOwner | SellCommon Stock · indirect | 12.3K | $7.00 | $86.3K | 1.65M |
| May 12, 2025Form 4 | 22NW Fund GP, LLC +4TenPercentOwner | SellCommon Stock · indirect | 45.7K | $7.03 | $321.3K | 1.66M |